Implementation of a Lung Cancer Nurse Navigator Enhances Patient Care and Delivery of Systemic Therapy at the British Columbia Cancer Agency, Vancouver

Zibrik, Kelly; Laskin, Janessa; Ho, Cheryl

doi:10.1200/jop.2015.008813

Cited by 17 publications

(12 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…With respect to treatment, patients were able to start systemic therapy a median of 10 calendar days sooner. Rates of molecular testing increased to 91% from 62%, while the proportion of patients with targetable mutations remained the same 12 . In addition, after nn implementation, molecular testing results were more often available at the time of the initial medical oncology consultation (37% vs. 6% before implementation), thereby reducing the number of repeat visits for the follow-up of outstanding tests and enabling appropriate medical therapy to be initiated more rapidly.…”

Section: Resultsmentioning

confidence: 99%

Integration of a Nurse Navigator into the Triage Process for Patients with Non-Small-Cell Lung Cancer: Creating Systematic Improvements in Patient Care

Zibrik

Laskin

2016

Current Oncology

View full text Add to dashboard Cite

Nurse navigation is a developing facet of oncology care. The concept of patient navigation was originally created in 1990 at the Harlem Hospital Center in New York City as a strategy to assist vulnerable and socially disadvantaged populations with timely access to breast cancer care. Since the mid-1990s, navigation programs have expanded to include many patient populations that require specialized management and prompt access to diagnostic and clinical resources. Advanced non-small-cell lung cancer is ideally suited for navigation to facilitate efficient assessment in this fragile patient population and to ensure timely results of molecular tests for first-line therapy with appropriately targeted agents. At the BC Cancer Agency, nurse navigator involvement with thoracic oncology triage has been demonstrated to increase the proportion of patients receiving systemic treatment, to shorten the time to delivery of systemic treatment, and to increase the rate of molecular testing and the number of patients with molecular testing results available at time of initial consultation. Insights gained through the start-up process are briefly discussed, and a framework for implementation at other institutions is outlined.

show abstract

Section: Resultsmentioning

confidence: 99%

Integration of a Nurse Navigator into the Triage Process for Patients with Non-Small-Cell Lung Cancer: Creating Systematic Improvements in Patient Care

Zibrik

Laskin

2016

Current Oncology

View full text Add to dashboard Cite

show abstract

“…35,39,40 A retrospective chart review evaluating the impact of patient navigation on time to treatment initiation in lung cancer patients found a significant decline in time from referral to primary consult, treatment, and radiation. 25 In comparison to usual care patients, navigated patients with lung cancer experienced an average reduction of 22 days from abnormal finding to treatment. 41,42 Navigated patients with abnormal breast, cervical, or colorectal screenings experienced significantly quicker times to diagnostic resolution at 6 months compared to usual care patients.…”

Section: Resultsmentioning

confidence: 99%

“…The bulk of studies occurred in the United States, 1 took place in Denmark, 23 and 2 in Canada. 24,25 The smallest sample size was 21 participants 26 and the largest was 5240 participants. 24 The majority of studies focused on black, Latino, or broadly vulnerable populations.…”

Section: Resultsmentioning

confidence: 99%

The Case for Patient Navigation in Lung Cancer Screening in Vulnerable Populations: A Systematic Review

Shusted

Barta

Lake

et al. 2019

Population Health Management

View full text Add to dashboard Cite

Patient navigation has been proposed to combat cancer disparities in vulnerable populations. Vulnerable populations often have poorer cancer outcomes and lower levels of screening, adherence, and treatment. Navigation has been studied in various cancers, but few studies have assessed navigation in lung cancer. Additionally, there is a lack of consistency in metrics to assess the quality of navigation programs. The authors conducted a systematic review of published cancer screening studies to identify quality metrics used in navigation programs, as well as to recommend standardized metrics to define excellence in lung cancer navigation. The authors included 26 studies evaluating navigation metrics in breast, cervical, colorectal, prostate, and lung cancer. After reviewing the literature, the authors propose the following navigation metrics for lung cancer screening programs: (1) screening rate, (2) compliance with follow-up, (3) time to treatment initiation, (4) patient satisfaction, (5) quality of life, (6) biopsy complications, and (7) cultural competency.

show abstract

“…Navigators have been shown to improve adherence to medication, completion of treatment, and reduce follow-up loss in chronic diseases requiring complex and prolonged treatment such as hemoglobinopathies, kidney transplant, and HIV (Sullivan et al, 2012;Mizuno et al, 2018;Allemang et al, 2019). Navigators have also been used for improving delivery of care in various cancers including lung, prostate, colorectal, and breast (Freeman et al, 1995;Fiscella et al, 2012;Wagner et al, 2014, dela Rama andPratz, 2015;Zibrik et al, 2016;DeGroff et al, 2017).…”

Section: Research Articlementioning

confidence: 99%

The Effect of a Patient Navigator on Treatment Abandonment and Follow-up for High Grade Osteosarcoma Patients in the Philippine General Hospital

Gaston

Taleon

Barsales

et al. 2021

Asian Pac J Cancer Prev

View full text Add to dashboard Cite

Introduction: Treatment abandonment for osteosarcoma is a significant problem in developing countries with rates as high as 70%. This study aimed to determine the effect of a patient navigator on treatment abandonment and patient follow-up of osteosarcoma patients at a tertiary referral center. Materials and Methods: A retrospective review of osteosarcoma patients was performed investigating 2 cohorts based on the start of the patient navigator. Group 1 (Pre-Patient Navigator, n=46) were treated from January 2016 to December 2017 while Group 2 (Post-Patient Navigator, n=29) were treated from January 2018 to June 2019. The primary outcome investigated was treatment abandonment defined as missing 4 or more consecutive weeks of treatment. Semi-structured interviews were conducted to investigate the effect of the patient navigator on the cohorts. Results: Treatment abandonment rates for the Pre-Patient Navigator group was significantly higher compared to those with a patient navigator (50% vs 6%, p=0.0001). Abandonment for the pre-navigator group occurred at a mean of 2.9 months (0 -9 months, median 3 months). Fourteen of 23 patients who abandoned from Group 1 did not proceed to neoadjuvant chemotherapy while 3 patients abandoned after completing 1 cycle of neoadjuvant chemotherapy. In the patient navigator group, no patients abandoned prior to completing 3 cycles of chemotherapy. One patient abandoned after refusing a below knee amputation after 3 cycles of neoadjuvant chemotherapy and 1 patient did not complete further chemotherapy after having a hip disarticulation. Patient feedback on the patient navigator experience was favorable. Conclusions: Having a patient navigator from diagnosis throughout treatment reduced treatment abandonment rates in osteosarcoma patients and may serve as a model for other low to middle income countries.

show abstract

Implementation of a Lung Cancer Nurse Navigator Enhances Patient Care and Delivery of Systemic Therapy at the British Columbia Cancer Agency, Vancouver

Abstract: Implementation of an NN was associated with reduced wait times and increased molecular testing, improving appropriate delivery of first-line targeted therapy. NN involvement facilitates correct allocation of physician and clinical resources.

Cited by 17 publications

References 11 publications

Integration of a Nurse Navigator into the Triage Process for Patients with Non-Small-Cell Lung Cancer: Creating Systematic Improvements in Patient Care

Integration of a Nurse Navigator into the Triage Process for Patients with Non-Small-Cell Lung Cancer: Creating Systematic Improvements in Patient Care

The Case for Patient Navigation in Lung Cancer Screening in Vulnerable Populations: A Systematic Review

The Effect of a Patient Navigator on Treatment Abandonment and Follow-up for High Grade Osteosarcoma Patients in the Philippine General Hospital

Contact Info

Product

Resources

About